ACEI or ARB Therapy for Left Ventricular Systolic Dysfunction-HF Patients
Percent of HF patients with LVSD who are prescribed an ACEI or ARB at hospital discharge. For purposes of this measure, LVSD is defined as chart documentation of a LVEF less than 40% or a narrative description of left ventricular systolic function consistent with moderate or severe systolic dysfunction.
Date Reviewed: November 7, 2015
Support
Facility
Population: Regional and State
Measure Info
NQF 0162NQF Endorsement Removed
Measure Type:
Process
Measure Steward:
Centers for Medicare and Medicaid Services
Clinical Topic Area:
Heart Failure
Care Setting:
Inpatient
Data Source:
Claims
Paper Medical Records
ACP supports this measure. The balance of evidence shows that long-term treatment with beta blockers and angiotensin converting enzyme inhibitors can lessen the symptoms of heart failure, improve the clinical status of patients and enhance the patient's overall sense of well-being. The measure aligns with current guidelines and represents high-value care.